| Net Loss Per Share |
16. Net Loss Per Share The following table sets forth the computation of basic and diluted net loss per share (in thousands, except share and per share amounts): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | June 30, | | June 30, | | 2026 | | 2025 | | 2026 | | 2025 | Numerator: | | | | | | | | | | | | Net loss | $ | (15,743) | | $ | (9,196) | | $ | (43,123) | | $ | (41,541) | Denominator: | | | | | | | | | | | | Weighted-average shares used to compute net loss per share, basic and diluted | | 86,398,778 | | | 6,316,315 | | | 86,021,323 | | | 6,240,885 | Net loss per share, basic and diluted | $ | (0.18) | | $ | (1.46) | | $ | (0.50) | | $ | (6.66) |
The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share for the periods presented because including them would have been antidilutive: | | | | | | | | | June 30, | | 2026 | | 2025 | Redeemable convertible preferred stock | — | | 122,231,454 | Outstanding options to purchase common stock | 9,716,691 | | 8,523,955 | Unvested restricted stock units | 1,836,862 | | — | Estimated ESPP | 141,184 | | — | Common stock warrants | — | | 1,647,667 | | 11,694,737 | | 132,403,076 |
|